Hypervascular Tumors
Contour SE designed to shrink, destroy uterine fibroids
Published in Women's Health Weekly, December 12th, 2002
Contour SE is made of polyvinyl acetate (PVA), a material that has been used extensively in embolization procedures for more than 20 years. Contour SE is designed to shrink and destroy hypervascular tumors and AVMs by blocking the blood supply feeding them.
The company also announced that it has received FDA authorization to perform a clinical trial (IDE) to evaluate uterine artery embolization (UAE) for the treatment of uterine fibroids (benign, smooth muscle tumors) using Contour SE. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Molecular tag pinpoints which tumors are most likely to spread - Women's Health Risk
Obesity increases risk of death from ovarian cancer in postmenopausal women - Cervical Cancer
American Cancer Society issues new early detection guidelines - Obstetrics
Leptin targeted in research on obesity, pregnancy - Ovarian Cancer
Neutralizing antibody plus paclitaxel diminish ovarian tumors - Stroke
Obese women have thicker carotid artery walls, higher stroke risk - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
